Overview

Equity fund that invests in securities of Swiss small and mid-cap companies.

Preference is given to stocks that are expected to perform better than average.

Important assessment criteria include not only the company’s valuation but also the economic environment, the company’s market positioning and the quality of the management.

Benefits

The fund uses the knowledge of proven specialists in small and mid-cap Swiss companies.

The fund managers can also draw on the knowledge and experience of equity analysts whose activities span the globe.

The fundamental valuation approach developed by UBS makes it possible to consistently identify the most attractive small and mid-cap Swiss companies.

Investors benefit from UBS SA国际传谋’s global investment platform.

Risks

UBS Small & Mid Cap Funds invest in equities and may therefore be subject to high fluctuations in value. As these UBS Funds pursue an active management style, each Fund's performance can deviate substantially from that of its reference index. Focusing intentionally on small cap equities may entail additional risks. All investments are subject to market fluctuations. Every Fund has specific risks, which can significantly increase under unusual market conditions. The fund can use derivatives, which may result in additional risks (particularly counterparty risk).

Features

Product category
UBS Equity Funds - UBS Small & Mid Cap Funds
Product domicile
Switzerland
Portfolio management
UBS SA国际传谋 Switzerland AG, Zurich
Fund management
UBS Fund Management (Switzerland) AG
Custodian bank
UBS Switzerland AG, Zurich
Day of inception
September 18, 2020
Currency of account
CHF
Close of financial year
May 31
SFDR Classification
n.a.
Issue / redemption
daily
Distribution
Reinvestment
Maturity
Open end
Ongoing costs p.a.
0.03% p.a.
Management fee
0.00% p.a.
Total expense ratio (TER)
0.02% p.a.
Swing pricing
yes
Minimum investment
n.a.
Reference Index / Benchmark
SPI EXTRA® (TR) in CHF
Securities no.
55256942
ISIN
CH0552569425
Bloomberg Ticker
CRCSEZC SW
Reuters Id
55256942X.CHE

Performance and Prices

Percentage growth

as of April 23, 2026
Cumulative
CHF(%) EUR(%) USD(%)
YTD 3.87 5.31 5.01
1M
3M
6M
1Y
2Y 13.98 14.96 30.39
3Y
5Y 7.09 28.92 25.29
ø p.a.5Y 1.38 5.21 4.61

Current data
Net asset value 23.04.2026 CHF 1,243.96
High - last 12 months 20.02.2026 CHF 1,271.67
Low - last 12 months 28.04.2025 CHF 1,064.46
Assets of the unit class in mn 23.04.2026 CHF 33.02
Total product assets in mn 23.04.2026 CHF 90.20
Statistical data
Date
2 years
5 years
Total risk reference index / benchmark 31.03.2026 10.50% 13.39%
Sharpe Ratio 31.03.2026 0.50 0.04
Risk Free Rate 31.03.2026 0.46% 0.40%

Structures

By the 10 largest positions (in %, as of March 31, 2026)

 
 
Sandoz Group AG 7.69
Galderma Group AG 7.41
Chocoladefabriken Lindt & Spruengli AG 6.02
Julius Baer Group Ltd 5.23
Helvetia Baloise Holding AG 5.09
SGS SA 5.00
Schindler Holding AG 4.98
Straumann Holding AG 3.59
Banque Cantonale Vaudoise 3.48
Roche Holding AG 2.86

Fees

Distributions

No distributions. Continuous reinvestment of income.

Sales Authorisations

Market
Sales authorisations status
Switzerland
Registered

Literature

en
de
fr
it
es
Brochures
Document type
Document Language
Fact Sheet
en en
it it
fr fr
es es
de de
ASIP ESG Report
Fact Sheet - UBS Equity Funds - UBS Small & Mid Cap Funds
de de
fr fr
it it
en en
es es
Agreement / Prospectus
Document type
Document Language
Prospectus
Key Information Document
Past performance
Previous performance scenario
Annual and semi-annual report (accounting on May 31)
Document type
Document Language
Annual report
Semi-annual report
Please wait for the requested content to load. If there is no response after several minutes, please reload the page or try again later.